2021 Abstract Guidelines & Poster Submission

The submission deadline will be December 31, 2020 11:59 PM ET. 

The 2021 posters will be available to view 24/7 via the virtual conference platform starting Monday, March 15; additionally, there will also be dedicated poster networking sessions as follows:

Monday, March 15 6:00-9:00 PM 

Tuesday, March 16 6:00-9:00 PM

Wednesday, March 17 6:30-9:00 AM

Thursday, March 18 12:00-1:30 PM

*All times subject to change

(all times are ET)


Abstract Submission Guidelines:

  • Oral presentations will be selected from abstracts submitted by the December 31, 2020 deadline. Those not selected for oral presentations will have the option of being presented as part of the virtual poster session. 

  • The first author (presenting author) will receive all future correspondence from MDA regarding the abstract.  

  • Abstract titles should be 150 characters including spaces. Abstract body should not exceed 300 words. 

  • Authors may submit abstracts on the following topics in neuromuscular disease (NMD) research and care:

    • Pre-Clinical Research

    • Translational Research

    • Clinical Trials 

    • Clinical Management 

    • Other


Poster Session Guidelines: 

  • Final submission can be via one-page PDF of your data. (PDF specs will be available soon!)

  • All submissions must include the first name, last name, and email address of the author best suited to answer questions. 

  • QR codes may be included as part of your poster to direct viewers to a download of your poster. 

  • Final submission deadlines, PDF specifications and the submission process will be announced shortly


MDA 2021 Embargo Policy

  • The embargo on all abstracts accepted for the 2021 MDA Virtual Clinical & Scientific Conference lifts on the date and time the abstract is publicly released by MDA.

  • While authors may publish that their poster has been selected for inclusion in the conference program, data from the final poster presentation may not be shared in any form (print, broadcast or online publication, media release or conference presentation) prior to its official presentation at MDA 2021. Authors retains copyright of his or her abstract and poster.

  • Encores are permitted provided that: (i) copyright requirements from the initial conference are respected and (ii) prior presentations are disclosed.

  • Questions about the abstract submission process or poster session guidelines, please contact Nicole Camacho at ncamacho@mdausa.org.